Table 1.
INDIRECT
EFFECTS |
Pathophysiological Mechanism | Methods | Bone Effects | References |
Nicotine causes an alteration in body weight, suppressing appetite and increasing dopamine and serotonin levels |
|
Weight loss causes a decrease in the mechanical load on the skeletal system, leading to a decrease in BMD | [23] | |
|
[24] | |||
|
[28] | |||
|
[26] | |||
Tobacco suppresses PTH, cholecalciferol, and calcitriol production Nicotine increases skin aging, causing it to lose its capacity to synthesize cholecalciferol |
|
The reduction in serum levels of PTH and consequent vitamin D activation causes a decrease in BMD | [33] | |
|
[34] | |||
|
[30] | |||
Smoking causes a decrease in testosterone levels Some alkaloids derived from tobacco inhibit the activity of the aromatic enzyme, exerting an antiestrogenic effects |
|
The decrease in gonadal hormone levels causes a reduction in the activity and proliferation of osteoblasts and an increase in the resorption activity of osteoclasts | [35] | |
|
[36] | |||
Smoking causes an increase in levels of adrenocorticotrophin, causing a consequent increase in circulating cortisol levels |
|
Cortisol causes a reduction in collagen and bone matrix synthesis | [41] | |
DIRECT
EFFECTS |
Smoking causes an increase in the RANKL/OPG ratio |
|
Increase in osteoclastogenesis and bone resorption | [45] |
|
[46] | |||
Smoking causes an increase in DKK1 (bone formation inhibitor) levels and a decrease in P1NP (bone formation marker) levels |
|
Alteration of bone formation | [30] |
BMI: bone mass index; BMD: bone mineral density; PTH: parathyroid hormone; MMP-1: metalloproteinase 1; qRT-PCR: quantitative real-time polymerase chain reaction; RANK: receptor activator of nuclear factor kappa-B; RANKL: receptor activator of nuclear factor kappa-B ligand; OPG: osteoprotegerin; DKK1: dickkopf-1; CTX-1: C-terminal telopeptide of collagen type 1; P1NP: N-terminal propeptide of procollagen; TNF-α: tumor necrosis factor-alpha.